Product
SARS-CoV-2 variant mRNA vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
An Open-Label, Phase 1 Clinical Study to Determine the Safety and Preliminary Immunogenicity of SARS-CoV-2 Variant mRNA Vaccine (LVRNA010) in Healthy Participants Aged 18 Years and OlderStatus: Not yet recruiting, Estimated PCD: 2023-05-01